Combination treatment of a PAPD5/7 inhibitor with an antisense oligonucleotide bepirovirsen with concurrent dosing shows additive HBsAg decreases in the AAV-HBV mouse model

Authors:
  • JDJared Delahaye
    Jared Delahaye
  • ELEdward Long
    Edward Long
  • CLChi Lau
    Chi Lau
  • JPJacob Parsons
    Jacob Parsons
  • BWBo Wen
    Bo Wen
  • ZCZhiyi Cui
    Zhiyi Cui
  • MPMelanie Paff
    Melanie Paff
  • SYShihyun You
    Shihyun You
  • MLMartin Leivers
    Martin Leivers

Abstract
No abstract available